Back to results
US 2019/0365930 A1Published application
Novel formulation
AssigneeGlaxosmithkline Biologicals SA
InventorsErwan BOURLES, Olivier DESPAS, Delphine GUILLAUME, Frederic MATHOT, Mathieu VASSELLE
Life of this patent
Estimating the term…
Abstract
The present invention relates to the formulation of adenoviral vectors in sorbitol containing compositions in combination with a further amorphous sugar, its formulation as well as a method for obtaining a dried composition.
Claims26
1-36. (canceled)
A composition comprising a recombinant simian adenoviral vector, sorbitol and an amorphous sugar selected from one or more of trehalose, sucrose, mannose, mannitol, raffinose and dextran.
Dependencies are inferred from the claim text.